About American Gene Technologies International
American Gene Technologies International is a private company based in Rockville, Maryland. It has reported $3,138,998 raised in four offerings on Form D since September 2013. Its chief executive is Jeffrey Galvin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2025 | Nov 18, 2025amended Dec 22, 2025 | $310,000of $10.0M target | 4 | $77,500 | Equity, SAFE (Simple Agreement for Future Equity)Rule 506(b) | Form D/A ↗1 earlier filing |
| Oct 30, 2015 | Nov 12, 2015 | $1,163,007of $4.3M target | 14 | $83,072 | EquityRule 506(b) | Form D ↗ |
| Sep 24, 2014 | Oct 3, 2014 | $340,992of $1.9M target | 1 | $340K | EquityRule 506(b) | Form D ↗ |
| Sep 3, 2013 | Sep 16, 2013 | $1,324,999fully sold | 2 | $662K | Equity06 | Form D ↗ |
| Total, four offerings | $3,138,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on American Gene Technologies International's Form D filed Dec 22, 2025.
WP
William Palin
Executive officer and director
JG
Jeffrey Galvin
Chief Executive Officer and director
BW
Barry Wells
Director